Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-017524
Filing Date
2018-06-20
Accepted
2018-06-20 20:46:25
Documents
2
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7062
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3655
  Complete submission text file 0000899243-18-017524.txt   12058
Mailing Address 245 FIRST STREET 4TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET 4TH FLOOR CAMBRIDGE MA 02142 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Scadden David (Reporting) CIK: 0001707715 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 18910731